IDT (NYSE:IDT) said its fiscal fourth quarter capped what management described as the strongest year in the company’s operational history, as growth in its higher-margin NRS, Fintech and net2phone businesses lifted revenue, gross profit and adjusted EBITDA to record levels. Chief Executive Officer Shmuel Jonas said each of the company’s three high-margin growth segments increased […]

Palatin Technologies (NYSEAMERICAN:PTN) said it is prioritizing development of next-generation melanocortin-4 receptor, or MC4R, agonists for rare and syndromic obesity disorders, while also seeking additional financing to support its programs and address a going-concern uncertainty disclosed alongside fiscal 2026 results. President and Chief Executive Officer Carl Spana said the company is initially targeting hypothalamic obesity, […]

Addex Therapeutics (NASDAQ:ADXN) reported a CHF 1.1 million operating loss for the first half of 2026, compared with CHF 1.3 million a year earlier, as reduced outsourced research and development spending on its GABAB positive allosteric modulator, or PAM, program lowered expenses. Chief Executive Officer Tim Dyer said the company also raised $2.8 million through […]

Orbit Garant Drilling (TSE:OGD) reported record quarterly and annual revenue for fiscal 2026 as drilling activity increased in Canada, Chile and Guyana, though higher operating costs, lower efficiency and ramp-up expenses on new contracts pressured profitability. Fourth-quarter revenue rose 21.3% year over year to C$57.2 million, while full-year revenue increased 7.5% to a record C$203.2 […]